Clinical Trials

Welcome to South East Retina Center –Clinical Trial Research Division!

Southeast Retina Center Clinical Trial Division has brought cutting edge therapies to our community and patients. Drs. Singh and Marcus have been clinical research investigators for many of the clinical trials investigating new state-of-the-art therapies for retinal diseases. Several of these therapies, such as anti-vascular endothelial growth factor (anti-VEGF) injections were evaluated in our office as part of clinical trials. Patients participating in clinical trials at Southeast Retina Center had the opportunity to receive therapies prior to their availability. Many treatments such as anti-VEGF injections were subsequently FDA approved and are now are standard treatment for many blinding retinal disorders such as wet age-related macular degeneration, diabetic retinopathy and retinal vein occlusion. Our clinical trial research division continues to study and evaluate new preventative and therapeutic treatments as we participate in numerous clinical trials and studies ranging from Phase I through Phase IV.

Drs. Singh and Marcus are national leaders in clinical research as they continue to offer our patients cutting edge therapies in trials sponsored by the National Eye Institute and leading pharmaceutical companies. Our practice has participated in the internationally recognized, National Eye Institute-sponsored Diabetic Retinopathy Clinical Research (DRCR) Network which is a leading entity for vital research for our diabetic patients. Dr. Marcus has served in several leadership roles for the Network including the DRCR executive committee, DRCR writing committees and protocol development committees. Dr. Marcus has served and continues to serve in a leadership position for several pharmaceutical study steering committees.

Our dedicated Certified Research staff brings extensive experience in quality data capture, visual function examinations, ophthalmic photography; OCT imaging; and ultrasonography with Cross-certification for various studies, strict protocol adherence and good clinical practice guidelines. Our site had been recognized as “Clinical Research Site of the Month” by the DRCR network.
Our imaging section performs anterior and posterior segment photography/fluorescein and indocyanine green angiography, posterior segment OCT (Cirrus, Heidelberg Spectralis ), HRT III, Corneal Topography (, microperimetry, and diagnostic and biometric ultrasonography .The visual field section employs Humphreperimeters and on-site electrophysiology testing. Biologic specimens are collected, centrifuged, stored (-20F and -86F freezers), packaged under CLIA accreditation and shipped by EHSO certified personnel.
This extensive experience in well-designed, controlled clinical trials has made us one of today’s leading Retina based research centres in Georgia. Our doctors take pride in offering the most promising vision-saving treatment to our patients.

Why consider us for as your next Research Site?

Our Facility boasts:

  • 1000 sq ft. Dedicated Clinical research wing
  • State-of-the-art imaging /diagnostic equipment
  • Dedicated, visual acuity testing room
  • Designated monitoring rooms with high speed internet and phone access
  • 4 dedicated experienced Certified clinical research coordinators
  • Dedicated RNs able to participate in Infusion studies
  • CPR and ACLS certified RNs
  • Certified Ophthalmic Technicians and Photographers
  • Trained personnel for handling/preparing for transportation of dangerous goods
  • Practice of Good Clinical Practice guidelines
  • Customized standard operating procedures
  • Excellent subject retention
  • Direct oversight by PI/Research Director

Trials and studies Current clinical trials at Southeast Retina center

Acucela SEATTLE Geographic Atrophy associated with Dry Age Related Macular Degeneration
Allergan PALM Diabetic Macular Edema
DRCR Treatment for Central Involved Diabetic Macular Edema with Very Good Visual Acuity Diabetic Macular Edema
DRCR Genes in Diabetic Retinopathy Project Diabetic Retinopathy
DRCR AA- Ultrawide-Field Imaging Non Proliferative Diabetic Retinopathy
DRCR Aflibercept, Bevacizumab and Ranibizumab Comparison Diabetic Macular Edema
Genentech OLEi Geographic Atrophy
Genentech/Roche CHROMA Geographic Atrophy secondary to Age Related Macular Degeneration
Genentech/Roche Eclips Subfoveal Neovascular Age Related Macular Degeneration
Pfizer B1261009 Diabetic Macular Edema
Regeneron ReVIEW Neovascular Age Related Macular Degeneration
Regeneron RIVAL Neovascular Polypoidal Choroidal Vasculopathy
Regeneron RANGE Wet Age Related Macular Degeneration
Regeneron HANDLE Wet Ocular Histoplasmosis


Past Clinical Trials

Sponsor Study Study Type
Alcon OSPREY Exudative Age Related Macular Degeneration
Genentech HIGH TIDE POLY Neovascular Polypoidal Choroidal Vasculopathy
Regeneron VISTA Diabetic Macular Edema
Regeneron VIEW 1 Ext Age Related Macular Degeneration
Regeneron VIBRANT Branch Retinal Vein Occlusion
DRCR EVA Low Contrast n/a
Quark Pharm. Quark Diabetic Macular Edema
Alimera FAME Diabetic Macular Edema
Genentech RETAIN Retinal Vein Occlusion
Alimera FAME Ext Diabetic Macular Edema
JDRF READ 3 Diabetic Macular Edema
Pfizer BioTx Dry Age Related Macular Degeneration
DRCR Protocol I Diabetic Macular Edema
DRCR Protocol N Vitreous Hemorrhage
Genentech MAHALO Geographic Atrophy
Pfizer B1181003 Geographic Atrophy
Lpath NEXUS Age Related Macular Degeneration
DRCR Protocol R Non Central Diabetic Macular Edema


If you are a Sponsor /CRO please contact the Clinical Research Manager- Christina Rex at 706-650-0061if you are interested in working with us as a site.

If you are a patient interested in determining your eligibility for a trial, please contact our Clinical Research Coordinators - Siobhan Ortiz CCRC, Coutney Caulder BS CCRC , or Allison Foster CRC at 706-650- 0061